Short-term effects of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
From the Department of Ophthalmology, University of Bonn, Bonn, Germany.
Peter
P
Charbel Issa
Hendrik P N
HP
Scholl
Frank G
FG
Holz